Increase in Industry Payments to Oncologists Tied to Marketing of Checkpoint Inhibitors
The mean value of payments to oncologists increased over time, as did the percentage of oncologists accepting industry payments.
All articles by Jon Kelvey
Many Oncology Drugs Approved for Genomic Indications Not Studied for Overall Survival Outcomes
Overall survival data were available for about half of the drugs.
COVID-19 Deaths on the Decline in Patients With Cancer
Registry data show significant decreases in 14-day and 3-month case-fatality rates.
- Loading...
Loading...
Next post in Oncology
Loading... 
Loading...